Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo

Fig. 8

Percentage of a CD4 +/CD3 + and (B) CD8 +/CD3 + T-cell population from spleenocytes of normal, negative control, AF2240-i, and rAF-IL12 groups after 28 days of treatment as analysed by flow cytometry. Data are presented as mean ± S.E.M. of six mice per group. Mean values with statistical difference at p ≤ 0.05 between groups are indicated with *

Back to article page